과제정보
The article is financially supported by the National Key Research and Development Program (2016YFD0501309).
참고문헌
- Wang Y, Wang Y, Sun L, Grenier D, Yi L. Streptococcus suis biofilm: regulation, drug-resistance mechanisms, and disinfection strategies. Appl Microbiol Biotechnol. 2018;102(21):9121-9129. https://doi.org/10.1007/s00253-018-9356-z
- Agass MJ, Willoughby CP, Bron AJ, Mitchell CJ, Mayon-White RT. Meningitis and endophthalmitis caused by Streptococcus suis type II (group R). BMJ. 1977;2(6080):167-168. https://doi.org/10.1136/bmj.2.6080.167
- Higgins R, Gottschalk M. Distribution of Streptococcus suis capsular types in 1994. Can Vet J. 1995;36(5):320.
- Perch B, Pedersen KB, Henrichsen J. Serology of capsulated streptococci pathogenic for pigs: six new serotypes of Streptococcus suis. J Clin Microbiol. 1983;17(6):993-996. https://doi.org/10.1128/jcm.17.6.993-996.1983
- Tian Y, Aarestrup FM, Lu CP. Characterization of Streptococcus suis serotype 7 isolates from diseased pigs in Denmark. Vet Microbiol. 2004;103(1-2):55-62. https://doi.org/10.1016/j.vetmic.2004.07.009
- Galina L, Collins JE, Pijoan C. Porcine Streptococcus suis in Minnesota. J Vet Diagn Invest. 1992;4(2):195-196. https://doi.org/10.1177/104063879200400216
- Heath PJ, Hunt B, Harwood DJ, Welchman DD. Isolation and identification of Streptococcus suis serotypes 3, 4 and 7. Vet Rec. 1995;136(21):547. https://doi.org/10.1136/vr.136.21.547
- Zhang CP, Ning YB, Zhang ZQ, Song L, Qiu HS, Gao HY, et al. Distributions of pathogenic capsular types and in vitro antimicrobial susceptibility of different serotypes of Streptococcus suis isolated from clinically healthy sows from 10 provinces in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2009;30(3):235-238.
- Goyette-Desjardins G, Auger JP, Xu J, Segura M, Gottschalk M. Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg Microbes Infect. 2014;3(6):e45.
- Salmon SA, Watts JL, Yancey RJ Jr. In vitro activity of ceftiofur and its primary metabolite, desfuroylceftiofur, against organisms of veterinary importance. J Vet Diagn Invest. 1996;8(3):332-336. https://doi.org/10.1177/104063879600800309
- Risco CA, Hernandez J. Comparison of ceftiofur hydrochloride and estradiol cypionate for metritis prevention and reproductive performance in dairy cows affected with retained fetal membranes. Theriogenology. 2003;60(1):47-58. https://doi.org/10.1016/S0093-691X(02)01299-2
- Xie S, Zhang X, Luo W, et al. Formulation, characterization and pharmacokinetics of long-acting ceftiofur hydrochloride suspension. Curr Drug Deliv. 2021;18(2):224-233. https://doi.org/10.2174/1567201817666200903165119
- Luo W, Chen D, Wu M, Li Z, Tao Y, Liu Q, et al. Pharmacokinetics/pharmacodynamics models of veterinary antimicrobial agents. J Vet Sci. 2019;20(5):e40. https://doi.org/10.4142/jvs.2019.20.e40
- Mitchell JD, McKellar QA, McKeever DJ. Evaluation of antimicrobial activity against Mycoplasma mycoides subsp. mycoides small colony using an in vitro dynamic dilution pharmacokinetic/pharmacodynamic model. J Med Microbiol. 2013;62(Pt 1):56-61. https://doi.org/10.1099/jmm.0.045971-0
- Marchetti S, Schellens JH. The impact of FDA and EMEA guidelines on drug development in relation to phase 0 trials. Br J Cancer. 2007;97(5):577-581. https://doi.org/10.1038/sj.bjc.6603925
- Nan J, Hao H, Xie S, Pan Y, Xi C, Mao F, et al. Pharmacokinetic and pharmacodynamic integration and modeling of acetylkitasamycin in swine for Clostridium perfringens. J Vet Pharmacol Ther. 2017;40(6):641-655. https://doi.org/10.1111/jvp.12404
- Mir O, Broutin S, Desnoyer A, Delahousse J, Chaput N, Paci A. Pharmacokinetics/pharmacodynamic (PK/PD) relationship of therapeutic monoclonal antibodies used in oncology: what's new? Eur J Cancer. 2020;128:103-106. https://doi.org/10.1016/j.ejca.2020.01.004
- Hohnstein FS, Meurer M, de Buhr N, von Kockritz-Blickwede M, Baums CG, Alber G, et al. Analysis of porcine pro- and anti-inflammatory cytokine induction by S. suis in vivo and in vitro. Pathogens. 2020;9(1):40. https://doi.org/10.3390/pathogens9010040
- Lee JY, Park HJ, Kim YK, Yu S, Chong YP, Kim SH, et al. Cellular profiles of bronchoalveolar lavage fluid and their prognostic significance for non-HIV-infected patients with Pneumocystis jirovecii pneumonia. J Clin Microbiol. 2015;53(4):1310-1316. https://doi.org/10.1128/JCM.03494-14
- Zhang M, Yang F, Yu HJ, Kang TJ, Ding YH, Yu ML, et al. Pharmacokinetics of ceftiofur sodium in cats following a single intravenous and subcutaneous injection. J Vet Pharmacol Ther. 2019;42(6):602-608. https://doi.org/10.1111/jvp.12814
- Wang J, Hao H, Huang L, Liu Z, Chen D, Yuan Z. Pharmacokinetic and pharmacodynamic integration and modeling of enrofloxacin in swine for Escherichia coli. Front Microbiol. 2016;7:36.
- Gastine S, Rashed AN, Hsia Y, Jackson C, Barker CI, Mathur S, et al. GAPPS (grading and assessment of pharmacokinetic-pharmacodynamic studies) a critical appraisal system for antimicrobial PKPD studies - development and application in pediatric antibiotic studies. Expert Rev Clin Pharmacol. 2019;12(12):1091-1098. https://doi.org/10.1080/17512433.2019.1695600
- Fernandez-Varon E, Carceles-Garcia C, Serrano-Rodriguez JM, Carceles-Rodriguez CM. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats. BMC Vet Res. 2016;12(1):232. https://doi.org/10.1186/s12917-016-0863-9
- Craigmill AL, Brown SA, Wetzlich SE, Gustafson CR, Arndt TS. Pharmacokinetics of ceftiofur and metabolites after single intravenous and intramuscular administration and multiple intramuscular administrations of ceftiofur sodium to sheep. J Vet Pharmacol Ther. 1997;20(2):139-144. https://doi.org/10.1046/j.1365-2885.1997.00820.x
- Olson SC, Beconi-Barker MG, Smith EB, Martin RA, Vidmar TJ, Adams LD. In vitro metabolism of ceftiofur in bovine tissues. J Vet Pharmacol Ther. 1998;21(2):112-120. https://doi.org/10.1046/j.1365-2885.1998.00118.x
- Zhou YF, Yu Y, Sun J, Tao MT, Zhou WJ, Li X, et al. Ex vivo pharmacokinetic/pharmacodynamic relationship of valnemulin against Clostridium perfringens in plasma, the small intestinal and caecal contents of rabbits. Anaerobe. 2016;39:150-157. https://doi.org/10.1016/j.anaerobe.2016.04.005
- Yan L, Xie S, Chen D, Pan Y, Tao Y, Qu W, et al. Pharmacokinetic and pharmacodynamic modeling of cyadox against Clostridium perfringens in swine. Sci Rep. 2017;7(1):4064. https://doi.org/10.1038/s41598-017-03970-9